Trial intelligence / Profile preview

Metformin in early stage breast cancer

NCT01266486Phase 2Completed

Sponsor
Oxford University Hospitals
Start
May 2011
Primary completion
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metformin in breast cancer, sponsored by Oxford University Hospitals. Started May 2011; status: completed.

02

Drugs

metformin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01266486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01266486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call